Diamantis P. Kofteridis

1.7k total citations · 1 hit paper
60 papers, 1.0k citations indexed

About

Diamantis P. Kofteridis is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Diamantis P. Kofteridis has authored 60 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 22 papers in Epidemiology and 14 papers in Molecular Medicine. Recurrent topics in Diamantis P. Kofteridis's work include Antibiotic Resistance in Bacteria (14 papers), Bacterial Identification and Susceptibility Testing (10 papers) and Antibiotic Use and Resistance (9 papers). Diamantis P. Kofteridis is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Bacterial Identification and Susceptibility Testing (10 papers) and Antibiotic Use and Resistance (9 papers). Diamantis P. Kofteridis collaborates with scholars based in Greece, United States and Belgium. Diamantis P. Kofteridis's co-authors include George Samonis, Matthew E. Falagas, Πέτρος Ιωάννου, Sofia Maraki, Dimitrios K. Matthaiou, Drosos E. Karageorgopoulos, Nikolaos Spernovasilis, Stella Baliou, S. K. Kasiakou and Antonios Valachis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Antimicrobial Chemotherapy and Food and Chemical Toxicology.

In The Last Decade

Diamantis P. Kofteridis

58 papers receiving 1.0k citations

Hit Papers

An analysis of existing national action plans for antimic... 2023 2026 2024 2025 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations
    2023 113 citations Diamantis P. Kofteridis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diamantis P. Kofteridis Greece 16 297 288 262 195 121 60 1.0k
Lennie Derde Netherlands 16 329 1.1× 348 1.2× 232 0.9× 160 0.8× 140 1.2× 41 1.1k
José Ramón Paño‐Pardo Spain 18 303 1.0× 272 0.9× 435 1.7× 250 1.3× 86 0.7× 55 1.1k
Hae Suk Cheong South Korea 18 289 1.0× 350 1.2× 430 1.6× 140 0.7× 174 1.4× 52 1.0k
Han Siong Toh Taiwan 18 261 0.9× 286 1.0× 251 1.0× 99 0.5× 224 1.9× 55 1.1k
Farzin Khorvash Iran 18 340 1.1× 210 0.7× 266 1.0× 87 0.4× 187 1.5× 109 1.1k
Rupali Jain United States 17 412 1.4× 335 1.2× 419 1.6× 144 0.7× 127 1.0× 55 1.1k
Oryan Henig Israel 14 288 1.0× 236 0.8× 183 0.7× 111 0.6× 100 0.8× 39 805
Jin-Won Chung South Korea 18 526 1.8× 333 1.2× 446 1.7× 156 0.8× 109 0.9× 70 1.2k
Michael Osthoff Switzerland 21 317 1.1× 183 0.6× 430 1.6× 193 1.0× 196 1.6× 94 1.6k
Renato Pascale Italy 17 203 0.7× 334 1.2× 286 1.1× 229 1.2× 60 0.5× 60 849

Countries citing papers authored by Diamantis P. Kofteridis

Since Specialization
Citations

This map shows the geographic impact of Diamantis P. Kofteridis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diamantis P. Kofteridis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diamantis P. Kofteridis more than expected).

Fields of papers citing papers by Diamantis P. Kofteridis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diamantis P. Kofteridis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diamantis P. Kofteridis. The network helps show where Diamantis P. Kofteridis may publish in the future.

Co-authorship network of co-authors of Diamantis P. Kofteridis

This figure shows the co-authorship network connecting the top 25 collaborators of Diamantis P. Kofteridis. A scholar is included among the top collaborators of Diamantis P. Kofteridis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diamantis P. Kofteridis. Diamantis P. Kofteridis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ιωάννου, Πέτρος, et al.. (2025). Kytococcus Species Infections in Humans—A Narrative Review. Microorganisms. 13(5). 1072–1072. 1 indexed citations
2.
Karakonstantis, Stamatis, Evangelos I. Kritsotakis, Nikolaos Tziolos, et al.. (2025). Mortality due to carbapenem-resistant Acinetobacter baumannii bacteraemia: a 5-year cohort study in intensive care patients. Clinical Microbiology and Infection. 31(6). 1033–1039. 1 indexed citations
3.
Schinas, Georgios, Οlga Tsachouridou, Konstantinos Protopapas, et al.. (2024). Prevalence of Hepatitis D in People Living with HIV: A National Cross-Sectional Pilot Study. Viruses. 16(7). 1044–1044. 1 indexed citations
4.
Schinas, Georgios, Οlga Tsachouridou, Konstantinos Protopapas, et al.. (2024). Testing Hepatitis E Seroprevalence among HIV-Infected Patients in Greece: The SHIP Study. Pathogens. 13(7). 536–536. 2 indexed citations
5.
Ιωάννου, Πέτρος, Stella Baliou, & Diamantis P. Kofteridis. (2024). Fungemia by Wickerhamomyces anomalus—A Narrative Review. Pathogens. 13(3). 269–269. 9 indexed citations
6.
Thomadakis, Christos, Dimitrios Basoulis, Οlga Tsachouridou, et al.. (2024). HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination. Viruses. 16(6). 885–885.
7.
Ιωάννου, Πέτρος, et al.. (2023). A Retrospective Study of Staphylococcus aureus Bacteremia in a Tertiary Hospital and Factors Associated with Mortality. Diagnostics. 13(11). 1975–1975. 4 indexed citations
8.
Ιωάννου, Πέτρος, Sofia Maraki, Dimitra Koumaki, et al.. (2023). A Six-Year Retrospective Study of Microbiological Characteristics and Antimicrobial Resistance in Specimens from a Tertiary Hospital’s Surgical Ward. Antibiotics. 12(3). 490–490. 4 indexed citations
9.
Ιωάννου, Πέτρος, et al.. (2023). Etiology of Anemia and Risk Factors of Mortality among Hospitalized Patients: A Real-Life Retrospective Study in a Tertiary Center in Greece. SHILAP Revista de lepidopterología. 15(2). 347–357. 2 indexed citations
10.
11.
Spanakis, Marios, Πέτρος Ιωάννου, Evridiki Patelarou, et al.. (2023). Evaluation of Drug Interactions in Hospitalized Patients with Respiratory Disorders in Greece. Advances in respiratory medicine. 91(1). 74–92. 1 indexed citations
12.
Spernovasilis, Nikolaos, et al.. (2023). A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 78(4). 1000–1008. 10 indexed citations
13.
14.
Messaritakis, Ippokratis, Elena Vakonaki, Georgios Chamilos, et al.. (2023). Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy. Microorganisms. 11(10). 2547–2547. 4 indexed citations
15.
Tziolos, Nikolaos, Πέτρος Ιωάννου, Stella Baliou, & Diamantis P. Kofteridis. (2023). Long COVID-19 Pathophysiology: What Do We Know So Far?. Microorganisms. 11(10). 2458–2458. 28 indexed citations
16.
Ιωάννου, Πέτρος, et al.. (2023). Pseudomonas Bacteremia in a Tertiary Hospital and Factors Associated with Mortality. Antibiotics. 12(4). 670–670. 16 indexed citations
17.
Saïdani, Nadia, Mark Gilchrist, R.A. Seaton, et al.. (2022). Survey of delivery of parenteral antimicrobials in non-inpatient settings across Europe. International Journal of Antimicrobial Agents. 59(4). 106559–106559. 12 indexed citations
18.
19.
Tsatsakis, Aristides, Daniela Călina, Luca Falzone, et al.. (2020). SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food and Chemical Toxicology. 146. 111769–111769. 113 indexed citations
20.
Kofteridis, Diamantis P., et al.. (2009). STAT4 Is Not Associated with Type 2 Diabetes in the Genetically Homogeneous Population of Crete. Genetic Testing and Molecular Biomarkers. 13(2). 281–284. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lennie Derde Breakdown of academic impact, for papers by José Ramón Paño‐Pardo Breakdown of academic impact, for papers by Hae Suk Cheong Breakdown of academic impact, for papers by Han Siong Toh Breakdown of academic impact, for papers by Farzin Khorvash Breakdown of academic impact, for papers by Rupali Jain Breakdown of academic impact, for papers by Oryan Henig Breakdown of academic impact, for papers by Jin-Won Chung Breakdown of academic impact, for papers by Michael Osthoff Breakdown of academic impact, for papers by Renato Pascale
Rankless by CCL
2026